ImmunoACT’s success in delivering India’s first indigenously developed CAR-T cell therapy has drawn renewed attention to the potential for cutting-edge R&D advances in the country.
Key Takeaways
-
India’s success in CAR-T therapies depicts effective collaboration between ecosystem stakeholders